Table 4.

Minimally Invasive Cohort Outcomes

Variable	Minimum (n=151)	VATS (n=97)	Robotic (n=54)	P value
Hospital stay (days)	2.0 ± 2.6	2.4 ± 3.2	1.3 ± 0.82	0.01
Operative time (min)	170.7 ± 82.0	161.1 ± 82.5	187.5 ± 78.3	0.06
ICU stay (days)	0.2 ± 1.3	0.3 ± 1.6	0.1 ± 0.41	0.23
Post-op complication
Re-operation	2 (1%)	2 (2%)	0	0.29
Arrhythmia	5 (35)	5 (5%)	0	0.82
Surgical site infection	1 (1%)	1 (1%)	0	0.45
Neurological deficit	0	0	0	1.00
Acute kidney injury	0	0	0	1
30 Day Readmission	8 (5%)	1 1%)	7 (13%)	<0.001
Total cost	14,504± 10,845	14,743 ± 13,113	14,075 ± 4,439	0.71
Non Thymoma	128 (85%)	85 (88%)	43 (80%)	0.28
Thymoma	23 (15%)	12 (12%)	11 (20%)
WHO classification
A	4 (3%)	1 (1%)	3 (6%)	0.51
AB	5 (3%)	5 (5%)	0	0.01
B1	8 (5%)	2 (2%)	6 (11%)	0.14
B2	4 (3%)	3 (3%)	1 (2%)	0.20
B3	2 (1%)	1 (1%)	1 (2%)	0.94
C	0	0	0	1.00
R0 resection	23 (1005)	12 (100%)	11 (100%)	1.00

^*Non Thymoma pathologies included: Thymic cyst, normal thymus, thymic hyperplasia